Clinical Research Details Clinical Research A phase 3, multi-center, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of reldesemtiv in patients with amyotrophic lateral sclerosis (als) (20211633) Study Description A phase 3, multi-center, double-blind, randomized, placebo-controlled trial to evaluate the efficacy and safety of reldesemtiv in patients with amyotrophic lateral sclerosis (als) (20211633) Investigators Michael T. Pulley, M.D., Ph.D. Neurology